Our customers are working harder than ever to make advancements in testing and development of vaccines for the novel coronavirus. Recently, NIH announced it is investing $248.7 million in new COVID-19 testing technologies to meet U.S. demand.
Learn more about the different point-of-care and lab-based tests, here.
Rees Scientific provides continuous automated monitoring to a limitless number of applications in a wide range of industries. From Pharmaceutical to Blood Banking, Laboratory Animal Research to Biotech and Hospitals, Rees has become the standard by which other monitoring systems are judged.
This post is related to:
